Stocktoria
DBV Technologies S.A. DBVT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-03-29
DBV Technologies S.A. statistics & valuation
Market cap$834.7M
P / B4.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -2609.2% | -2808.7% | -486.0% | -1994.9% | -1727.6% |
| Net margin | -2607.3% | -2744.4% | -462.4% | -1987.5% | -1713.5% |
| FCF margin | -2159.6% | -2573.2% | -510.7% | -1164.7% | -1912.3% |
| Return on assets | -62.9% | -173.5% | -39.7% | -39.1% | -66.7% |
| Return on equity | -87.1% | -415.8% | -51.9% | -49.5% | -98.5% |
| Debt / equity | — | — | — | — | 0.01× |
| Current ratio | 3.67 | 1.43 | 4.26 | 7.56 | 3.64 |
| Revenue growth | 35.8% | -73.6% | 224.7% | -15.1% | -49.4% |
Source: SEC EDGAR filings · CIK 0001613780 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.